daily

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TE

Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence rates, fewer inpatient, outpatient and emergency department (ED)…

7 months ago

How to make over $10,000 a day: XRP enthusiasts realize their dreams on the SAVVY MINING platform.

New York City, USA, May 30, 2025 (GLOBE NEWSWIRE) -- XRP is back in the spotlight—and this time, it’s not…

7 months ago
Show previous Posts